Effect of differentiating agents (all-trans retinoic acid and phorbol 12-myristate 13-acetate) on drug sensitivity of HL60 and NB4 cells in vitro

Folia Histochemica et Cytobiologica

Volumn 46, Issue 3, 2008, Pages 323-330

  Jasek, Ewa ^a   Mirecka, Jadwiga ^a   Litwin, Jan A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Apoptosis; ATRA; Differentiation; Leukemia; PMA

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN NB 4; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MYELOID LEUKEMIA; NEUTROPHIL; SURVIVAL RATE; DRUG EFFECT; METABOLISM; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HL-60 CELLS; HUMANS; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRETINOIN;

EID: 58949083252     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0080-x     Document Type: Article

References (44)

1. Idres N, Benoit G, Flexor MA, Lannote M, Chabot GG. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Cancer Res. 2001;15:700-705.
2. Kambhampati S, Verma A, Li Y, Parmar S, Sassano A, Platanias LC. Signalling pathways activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Leuk Lymph. 2004;45:2175-85.
3. Zhang JW, Wang JY, Chen SJ, Chen Z. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J Biosci. 2000;25:275-284.
4. Gate L, Lunk A, Tew K. Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase π inhibitor. Biochem Pharmacol. 2003;65:1611-1622.
5. Yang M, Chen T, Han C, Li N, Wan T, Cao X. Rab7b, a novel lysosome-associated small GTPase, is involved in monocytic differentiation of human acute promyelocytic leukemia cells. Biochem Biophys Res Commun. 2004;318:792-799.
6. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia. 2002;16:1896-1905.
7. Oren T, Sher JA, Evans T. Hematopoiesis and retinoids. Leuk Lymph. 2003;44:1881-1891.
8. Zile MH. Function of vitamin A in vertebrate embryonic development. J Nutr. 2001;131:705-708.
9. Gutcher I, Webb PR, Anderson NG. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci. 2003;60:1061-1070.
10. Nakashima S. Protein kinase Cα (PKCα): regulation and biological function. J Biochem. 2002;132:669-675.
11. Bolanos-Meade J, Karp JE, Guo C, Adoo CB, Rapoport AP, Tidwell ML et al. Timed sequential therapy of acute myelogenous leukaemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide. Leuk Res. 2003;27: 313-321.
12. Degos L, Wang ZY. All-trans retinoic acid in acute promyelocytic leukemia. Oncogene. 2001;29:7140-7145.
13. Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol. 2001;38:13-25.
14. Vitoux D, Nasr R, de The H. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response. Int J Biochem Cell Biol. 2007;39:1063-70.
15. Zhou GB, Chen SJ, Chen Z. Grant S. Acute promyelocytic leukemia: a model of molecular target based therapy. Hematology. 2005;10:270-280.
16. Hu ZB, Minden MD, McCulloch EA. Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid. Blood. 1998;5:1768-1775.
17. + acute promyelocytic leukemia. Leukemia. 2003;17:98-113.
18. 3 or 12-O-tetradecanoyl phorbol- 13-acetate. Leuk Res. 1998;22:537-547.
19. Miyauchi J, Ohyashiki K, Inatomi Y, Toyama K. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood. 1997;15:803-813.
20. Allouche M, Charrad RS, Bettaieb A, Greenland C, Grignon C, Smadja-Joffe F. Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood. 2000;96:1187-1190.
21. Gianni M, Kalac Y, Ponzanelli I, Rambaldi A, Terao M, Garattini E. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid promyelocytic leukemia cells: effects on the degradation of RARα and PML-RARα. Blood. 2001; 97:3234-3242.
22. 3, and granulocyte-macrophage colony-stimulating factor. Blood. 1997;90:4578-4587.
23. Solary E. Positive and negative regulation of apoptotic pathways by cytotoxic agents in haematological malignances. Leukemia. 2000;14:1833-1849.
24. Sordet O, Rebe C, Leroy I, Bruey JM, Garrido C, Miguet C et al. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Blood. 2001;12:3931-3939.
25. Xia L, Wurmbach E, Jing Y. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis. Leukemia. 2006;20:1009-1016.
26. Otake Y, Sengupta TK, Bandyopadhyay S, Spicer EK, Fernandez DJ. Retinoid induces apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA. Mol Pharmacol. 2005;67:319-326.
27. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med. 2001;6:680-686.
28. Bruserud O, Gjertsen BT. New strategies for the treatment of acute myelogenous leukemia: differentiation induction - present use and future possibilities. Stem Cells. 2000;18:157-165.
29. Takagaki K, Katsuma S, Kaminishi Y, Horio T, Tanaka T, Ohgi T et al. Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells. Genes Cells. 2005;10:97-106.
30. Johns LD, Sarr T, Ranges GE. Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B. J Immunol. 1994;15:5877-5882.
31. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. Fas-ligand independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem. 1999; 274:7987-7992.
32. Meinhardt G, Roth J, Hass R. Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis. Cell Death Differ. 2000;7:795-803.
33. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
34. Sordet O, Bettaieb A, Bruey JM, Eymin B, Droin N, Ivarsson M et al. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ. 1999;6:351-361.
35. Wang J, Barsky LW, Shum CH, Jong A, Weinberg KI, Collins SJ et al. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor. J Biol Chem. 2002;277:43369-43376.
36. Gieseler F, Bauer E, Nuessler V, Clark M, Valsamas S. Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage. Leukemia. 1999;13:1859-1863.
37. 3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Exp Cell Res. 2004;294: 301-311.
38. Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH et al. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood. 2001;97:264-269.
39. Yin W, Raffelsberger W, Gronemeyer H. Retinoic acid determines life span of leukemic cells by inducing antagonistic apoptosis-regulatory programs. Int J Biochem Cell Biol. 2005;37:1696-1708.
40. Konopleva M, Zhao S, Hu W, Jiang S, Snell V, Weidner D et al. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells. Br J Haematol. 2002;118:521-534.
41. Come MG, Skladanowski A, Larsen AK, Laurent G. Dual mechanism of daunorubicin-induced cell death in both sensitive and MDR-resistant HL60 cells. Br J Cancer. 1999;79: 1090-1097.
42. Laurent G, Jaffrezou JP. Signaling pathways activated by daunorubicin. Blood. 2001;98:913-924.
43. Bjorling-Poulsen M, Issinger OG. cDNA array analysis of alterations in gene expression in the promyelocytic leukemia cell line, HL-60, after apoptosis induction with etoposide. Apoptosis. 2003;8:377-388.
44. Lee KH, Chang MY, Ahn JI, Yu DH, Jung SS, Choi JH et al. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun. 2002;296:1125-1133.